125 related articles for article (PubMed ID: 8634660)
1. Increased expression of cytokeratins CK8 and CK19 is associated with head and neck carcinogenesis.
Xu XC; Lee JS; Lippman SM; Ro JY; Hong WK; Lotan R
Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):871-6. PubMed ID: 8634660
[TBL] [Abstract][Full Text] [Related]
2. CK8 correlates with malignancy in leukoplakia and carcinomas of the head and neck.
Gires O; Mack B; Rauch J; Matthias C
Biochem Biophys Res Commun; 2006 Apr; 343(1):252-9. PubMed ID: 16540085
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues.
Xu XC; Ro JY; Lee JS; Shin DM; Hong WK; Lotan R
Cancer Res; 1994 Jul; 54(13):3580-7. PubMed ID: 8012985
[TBL] [Abstract][Full Text] [Related]
4. Quantitative expression study of four cytokeratins and p63 in squamous cell carcinoma of the tongue: suitability for sentinel node navigation surgery using one-step nucleic acid amplification.
Yamauchi K; Fujioka Y; Kogashiwa Y; Kohno N
J Clin Pathol; 2011 Oct; 64(10):875-9. PubMed ID: 21705376
[TBL] [Abstract][Full Text] [Related]
5. Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers.
Lotan R
Anticancer Res; 1996; 16(4C):2415-9. PubMed ID: 8816844
[TBL] [Abstract][Full Text] [Related]
6. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis.
Shin DM; Kim J; Ro JY; Hittelman J; Roth JA; Hong WK; Hittelman WN
Cancer Res; 1994 Jan; 54(2):321-6. PubMed ID: 8275461
[TBL] [Abstract][Full Text] [Related]
7. p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis.
Shin DM; Charuruks N; Lippman SM; Lee JJ; Ro JY; Hong WK; Hittelman WN
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):603-9. PubMed ID: 11401909
[TBL] [Abstract][Full Text] [Related]
8. Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis.
Tae K; El-Naggar AK; Yoo E; Feng L; Lee JJ; Hong WK; Hittelman WN; Shin DM
Clin Cancer Res; 2000 Jul; 6(7):2821-8. PubMed ID: 10914730
[TBL] [Abstract][Full Text] [Related]
9. Is the carbohydrate sialosyl-Tn a marker for altered, non-malignant activity in squamous epithelium in the head and neck region?
Bryne M; Gravdahl C; Koppang HS; Kjaerheim A; Dabelsteen E
J Pathol; 1995 Feb; 175(2):237-42. PubMed ID: 7738720
[TBL] [Abstract][Full Text] [Related]
10. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
11. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
12. The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies.
Christensen ME
Dan Med Bull; 1998 Apr; 45(2):121-34. PubMed ID: 9587699
[TBL] [Abstract][Full Text] [Related]
13. Comparison of differentiation markers between normal and two squamous cell carcinoma cell lines in culture.
Gasparoni A; Fonzi L; Schneider GB; Wertz PW; Johnson GK; Squier CA
Arch Oral Biol; 2004 Aug; 49(8):653-64. PubMed ID: 15196983
[TBL] [Abstract][Full Text] [Related]
14. Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma.
Rubin Grandis J; Tweardy DJ; Melhem MF
Clin Cancer Res; 1998 Jan; 4(1):13-20. PubMed ID: 9516947
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of basaloid squamous cell carcinoma, adenoid cystic and mucoepidermoid carcinoma in the upper aerodigestive tract.
Tsubochi H; Suzuki T; Suzuki S; Ohashi Y; Ishibashi S; Moriya T; Fujimura S; Sasano H
Anticancer Res; 2000; 20(2B):1205-11. PubMed ID: 10810423
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
[TBL] [Abstract][Full Text] [Related]
17. CD44s and CD44v6 expression in head and neck epithelia.
Mack B; Gires O
PLoS One; 2008; 3(10):e3360. PubMed ID: 18852874
[TBL] [Abstract][Full Text] [Related]
18. Expression of the extra domain B of fibronectin, a marker of angiogenesis, in head and neck tumors.
Birchler MT; Milisavlijevic D; Pfaltz M; Neri D; Odermatt B; Schmid S; Stoeckli SJ
Laryngoscope; 2003 Jul; 113(7):1231-7. PubMed ID: 12838025
[TBL] [Abstract][Full Text] [Related]
19. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
Zhong LP; Zhang CP; Zheng JW; Li J; Chen WT; Zhang ZY
Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic marker.
Kawakami M; Kawakami K; Kasperbauer JL; Hinkley LL; Tsukuda M; Strome SE; Puri RK
Clin Cancer Res; 2003 Dec; 9(17):6381-8. PubMed ID: 14695138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
